Announcements Trials
Browse Landscape

Phase

Phase 1 4

Status

Completed 3Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Renal Cell 13Neoplasm Metastasis 12Prostatic Neoplasms 9Neoplasms 7Glioblastoma 7Kidney Neoplasms 6Brain Neoplasms 6Sarcoma 5Carcinoma, Hepatocellular 5Ovarian Neoplasms 4Lymphoma, Non-Hodgkin 4Glioma 4Endometrial Neoplasms 4Colorectal Neoplasms 4Central Nervous System Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Breast Neoplasms 4Advanced Cancer 4Uterine Cervical Neoplasms 3Recurrence 3Pancreatic Neoplasms 3Oligodendroglioma 3Multiple Myeloma 3Lymphoma, Mantle-Cell 3Liver Neoplasms 3Astrocytoma 3Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Solid Tumors 2

Interventions

Surveys and Questionnaires 7Standard of Care 5Sirolimus 5Bevacizumab 5temsirolimus 4Interviews as Topic 4Paclitaxel 3olaparib 2Vorinostat 2Olanzapine 2Magnetic Resonance Spectroscopy 2Gemcitabine 2Everolimus 2Erlotinib Hydrochloride 2Dasatinib 2Cetuximab 2zaleplon 1vistusertib 1tilsotolimod 1pazopanib 1olanzapine-fluoxetine combination 1nimotuzumab 1liposomal doxorubicin 1capivasertib 1apatinib 1Videotape Recording 1Vemurafenib 1Valproic Acid 1Trastuzumab 1Topotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Advanced Cancer × temsirolimus × Clear all
NCT01087554 2026-01-16

Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
249 enrolled

Advanced Cancer

NCT01596140 2020-06-04

Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
27 enrolled
Other solid neoplasm

Advanced Cancer

NCT00610493 2017-12-08

Bevacizumab and Temsirolimus in Patients With Advanced Malignancy

M.D. Anderson Cancer Center

Phase 1 Completed
193 enrolled

Advanced Cancer

NCT00770731 2013-02-13

Study of Temsirolimus, Topotecan, and Bortezomib

M.D. Anderson Cancer Center

Phase 1 Completed
80 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡